<?xml version="1.0" ?>
<tei>
	<teiHeader>
		<fileDesc xml:id="55006647"/>
	</teiHeader>
	<text xml:lang="en">
		<front>
<lb/>
	<note type="copyright">Â© 2002 Oxford University Press<lb/></note>

	<reference>Nucleic Acids Research Supplement No. 2 147-148<lb/></reference>

	<docTitle>
	<titlePart>Synthesis and properties of oligonucleotides containing<lb/> novel 2&apos;,4&apos;-BNA analogues (2<lb/> 1<lb/> ,4&apos;-BNA<lb/> COC<lb/> )<lb/></titlePart>
	</docTitle>

	<byline>
	<docAuthor>Yoshiyuki Hari, Tomohisa Osaki, Ken Eguchi, Satoshi Obika and Takeshi Imanishi<lb/></docAuthor>
	</byline>

	<byline>
	<affiliation>Graduate School of Pharmaceutical Sciences, Osaka University,</affiliation>
	</byline>

	<address>1 -6 Yamadaoka, Suita, Osaka 565-<lb/>0871,Japan<lb/></address>

	<div type="abstract">ABSTRACT Preorganization of the nucleoside into proper<lb/> conformation is one of the most promising approaches to<lb/> develop the oligonucleotides strongly interacting with<lb/> nucleic acid targets in a sequence-specific manner. We<lb/> designed and synthesized the 2&apos;,4&apos;-BNA<lb/> C0C monomer as<lb/> a novel bridged nucleic acid analogue possessing a fixed<lb/> N-type sugar conformation, and also successfully<lb/> achieved its incorporation into oligonucleotides. The<lb/> 2&apos;,4&apos;-BNA<lb/> coc modified oligonucleotides were found to<lb/> have selective and strong binding-affinity<lb/> for complementary RNA rather than DNA, and to show an<lb/> excellent nuclease resistance ability.<lb/></div>

		</front>
	</text>
</tei>
